IL6 and familial pancreatic carcinoma: Our previous study has shown that bazedoxifene is capable of blocking the IL6/GP130/STAT3 signaling pathway by inhibiting IL6‐induced homodimerization of GP130, leading to a potential antitumor effect, which has been demonstrated in triple‐negative breast cancer and pancreatic cancer [15, 16, 17].